Device: integra titan modular shoulder system 2.5 (DrugBank: Titan)
1 diseaseID | Disease name (Link within this page) | Number of trials |
---|---|---|
46 | Malignant rheumatoid arthritis | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT03250767 (ClinicalTrials.gov) | August 1, 2017 | 11/8/2017 | Clinical Evaluation of the Integra® Titan™ Modular Shoulder System Generation 2.5 for Primary Shoulder Joint Replacement | A Post-Market, Prospective, Multi-Center, Open-Label, Single Arm Clinical Evaluation of the Integra® Titan™ Modular Shoulder System Generation 2.5 for Primary Shoulder Joint Replacement | Osteo Arthritis Shoulders;Traumatic Arthritis;Rheumatoid Arthritis | Device: Integra Titan Modular Shoulder System 2.5 | Integra LifeSciences Corporation | NULL | Recruiting | 18 Years | N/A | All | 140 | United States |